Twin Peaks Wealth Advisors, LLC Charles River Laboratories International, Inc. Transaction History
Twin Peaks Wealth Advisors, LLC
- $309 Billion
- Q2 2025
A detailed history of Twin Peaks Wealth Advisors, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Twin Peaks Wealth Advisors, LLC holds 45 shares of CRL stock, worth $7,654. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45Holding current value
$7,654% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CRL
# of Institutions
615Shares Held
52.7MCall Options Held
1.42MPut Options Held
1.42M-
Vanguard Group Inc Valley Forge, PA5.81MShares$989 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$865 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.77MShares$641 Million0.11% of portfolio
-
Allspring Global Investments Holdings, LLC2.29MShares$390 Million0.63% of portfolio
-
State Street Corp Boston, MA1.86MShares$316 Million0.01% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.65B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...